Hypertrophic Cardiomyopathy Dysfunction Mimicked in Human Engineered Heart Tissue and Improved by SGLT2 Inhibitors

Contractility was measured of human induced pluripotent stem cell-derived cardiomyocytes harboring a hypertrophic cardiomyopathy mutation cultured in 2D and in 3D engineered heart tissue.